One in 31 hospital patients will acquire a hospital-acquired infection (HAI) during their care. This is not a rare complication, rather a systemic risk. The good news is that a significant portion of it is preventable.
How does it happen? Here's a typical scenario:
A sterile tray arrives in the operating room. The packaging is intact. The indicator has changed. The sterilizer printout looks perfect. And yet the instrument inside may still pose an infection risk to the patient on the table.
Hospitals have reported cases in which sterilized surgical instruments were contaminated with organic material from a prior procedure, something healthcare workers call bioburden. While most of these cases are recognized before the devices reach the patient, in some instances, soiled instruments have contaminated sterile fields. In those instances, patients face a real risk of a hospital-acquired infection or surgical site infection, sometimes before the first incision.
Understanding how this happens... and how to stop it... begins in the sterile processing department, long before the instrument reaches the OR.
What is Bioburden?
Bioburden refers to the biological material still present on a surgical instrument after using blood, tissue debris, proteins, and microorganisms that accumulate during a procedure. Every reusable surgical instrument carries some level of bioburden after a case. The reprocessing cycle and sterile processing are in place to remove it.
What most hospital leaders outside of SPD do not fully appreciate is the relationship between cleaning and sterilization. Instrument reprocessing is not a single step. Instead, it is a chain of many steps, often dependent on each other. If early cleaning steps are missed, downstream processes become less effective. Sterilization does not replace cleaning. It completes it. An instrument that enters the sterilizer with bioburden still present may emerge with sterility indicators showing a passed cycle while residual organic material remains on the instrument surface.
The CDC's Guideline for the Prevention of Surgical Site Infection notes that microbial contamination of the surgical site is a necessary precursor of a surgical infection. The pathway from an inadequately cleaned instrument to a surgical site infection is clinically documented and preventable.
How Bioburden Leads to Infection Risk
The reprocessing breakdown almost always begins before an instrument reaches SPD. Point-of-use pretreatment prevents bioburden from drying onto instruments. If dried soil reaches the SPD, it increases cleaning difficulty and delays turnover, affecting ultrasonic cleaning performance because cavitation and chemistry work best when gross debris has already been removed, and soil has not hardened into crevices.
Once dried, bioburden reaches the decontamination area, the cleaning challenge increases substantially. Manual cleaning of complex instruments, particularly robotic instruments and endoscopes, requires manufacturer-specific techniques. Bioburden is not always visible to the human eye, so a visual check alone is not sufficient to ensure that reprocessing was successful and that instruments are safe for use on new patients.
Inadequate or improper cleaning prior to sterilization can also allow residual bioburden to harbor microtoxins. The consequence at the patient level is significant. Data from the CDC indicates that over 30,000 patients die annually from surgical infections, and the majority of deaths are related to serious infections involving organs or spaces accessed during the operation.
What SPD Practices Directly Control Bioburden
For OR managers and SPD leaders making the case internally, these are the areas where process discipline most directly affects patient safety outcomes.
Point-of-use treatment. What happens in the OR immediately after a case determines how effectively SPD can clean the instrument. Instruments should be kept moist and pre-treated before transport. This is a shared responsibility between OR staff and SPD, and one of the most common points of breakdown.
Manual cleaning protocols. Manual cleaning should be performed on all instruments, but may be recommended as the preferred method for delicate or complex devices such as endoscopes or microsurgical instruments. Staff must be trained and competency-verified in accordance with the specific manufacturer's instructions for use for each device type. Generic cleaning protocols applied to complex instruments are a documented source of reprocessing failure.
Washer-disinfectant validation. Automated cleaning cycles must be run according to manufacturer-specified parameters and consistently monitored. A completed cycle is not the same as a performing cycle. Temperature, chemical concentration, and cycle time all affect cleaning efficacy and need documented validation.
Bioburden testing. ATP testing measures remaining bioburden through light detection and provides a faster, more objective readout than visual inspection alone. Departments using this testing as part of a routine quality program catch failures that visual checks miss entirely.
Staff training and stability. Every protocol is only as reliable as the person performing it. High staff turnover in SPD means newer technicians who may not yet be competent with complex instrument types might indirectly fill the gap, creating a direct patient safety risk. Stable, well-trained SPD teams are among the most effective investments a hospital can make in infection prevention.
What Joint Commission Compliance Surveyors Look For
Under Accreditation 360, the Joint Commission has shifted focus from documentation compliance to demonstrated practice. For SPD teams, this means surveyors are looking at whether reprocessing protocols are followed consistently in daily practice, not just written down. Cleaning validation records, staff competency documentation, and point-of-use treatment practices are all areas where gaps surface during surveys.
A bioburden-related finding is not just a compliance issue. Under the updated model, it is a patient safety event that can trigger a more intensive follow-up review. Hospitals that discover these gaps during a survey are already behind. The goal is to find and close them first.
For more on preparing your SPD for Accreditation 360, see our complete guide to the updated Joint Commission standards.
The Role of OR Support in Infection Prevention (IP)
One of the most underutilized infection prevention strategies in perioperative care is having dedicated OR support personnel who understand reprocessing requirements and can flag concerns at the point of use before a compromised instrument ever leaves the room. When OR liaisons are embedded in the surgical environment and fluent in reprocessing protocols, they become the first line of defense in the bioburden chain.
For more information on how this role affects both efficiency and patient outcomes, check out our post on OR liaisons.
What Stronger SPD Performance Means for Patients
When SPD operates with validated cleaning protocols, trained and stable staff, and real-time visibility into performance, bioburden control improves. When bioburden control improves, sterilization is more effective. When sterilization is more effective, the instruments that reach your OR are what they appear to be. And ultimately, the patients on our hospital tables carry less risk of preventable harm.
The connection is not theoretical. It is measurable, documentable, and directly tied to the operational decisions hospital leaders make about how their sterile processing department is staffed, supervised, and supported.
If your SPD does not currently have a formal bioburden monitoring program, validated cleaning protocols for complex instruments or a stable team that is competency-verified across all device types, those are gaps worth closing now.
The cost of waiting can range from a failed survey to something far worse: a hospital-acquired infection that is entirely preventable.
Ready to assess where your SPD stands?
Let’s discuss this in detail with the team at Surgical Solutions.
What is bioburden in a hospital setting?
Bioburden refers to the biological material: blood, tissue debris, proteins, and microorganisms present on a surgical instrument after use. Every reusable instrument carries some level of bioburden following a procedure. The sterile processing department is responsible for removing it through a validated cleaning and sterilization process before the instrument is used again on another patient.
Can a sterilized instrument still cause a hospital-acquired infection?
Yes! And this is one of the most important things hospital leaders outside of SPD need to understand. Sterilization is only effective when cleaning has been completed properly first. An instrument that enters the sterilizer with residual bioburden may pass all sterility indicators while still carrying organic material that poses an infection risk. The CDC notes that microbial contamination of the surgical site is a necessary precursor of a surgical infection, and that contamination can originate from an inadequately cleaned instrument.
What causes reprocessing failures in sterile processing?
The most common causes include inadequate point-of-use treatment, insufficient manual cleaning of complex instruments, washer cycles running outside validated parameters and staff who have not been competency-verified on manufacturer reprocessing instructions. High SPD turnover increases the risk of all of these at once.
How do hospital-acquired infections affect a hospital financially?
HAIs are among the most expensive complications in healthcare. CMS does not reimburse hospitals for certain hospital-acquired infections, meaning the full cost of treatment, extended length of stay and liability exposure falls directly on the institution. Prevention through stronger SPD protocols and validated reprocessing practices is significantly less expensive than treating an HAI after the fact.
What should hospital leaders look for as early warning signs of a bioburden problem in SPD?
High instrument return rates, visible soil on instruments after decontamination, failed biological indicators in sterilization monitoring, and Joint Commission findings related to reprocessing are all signals worth taking seriously. Any of these warrants an immediate review of SPD cleaning protocols, staff competency records, and point-of-use treatment practices in the OR.
Surgical-solutions Blog: 5 Common Operational Inefficiencies in Hospitals (and How to Fix Them)
Surgical-Solutions Blog: Accreditation 360: What Joint Commission Surveyors Are Really Asking in Sterile Processing